-
Mashup Score: 3A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma - 7 hour(s) ago
IPH6501, a CD20-targeted NK cell engager armed with non-alpha IL-2, shows preclinical efficacy and tolerability in B-NHL.
Source: www.science.orgCategories: General Medicine News, Allergy-ImmunologyTweet
New preclinical research from @EricVivier1 highlights the promise of #NaturalKillerCell engagers that induce antitumor activity against B cell non-Hodgkin #lymphoma. @DemariaO More in Science #Immunology: https://t.co/ZrkBnYnWsw https://t.co/jI0azWJbuz